Proprio Raises $43m Series B Funding to Fuel Commercialisation
First light field-enabled surgical technology company secures additional institutional capital to drive adoption of its AI-driven platform
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jul 23
First light field-enabled surgical technology company secures additional institutional capital to drive adoption of its AI-driven platform
28 Jul 23
SCONE and SCiP are two FDA-designated Breakthrough Devices being developed by SpineX for the treatment of adults with…
27 Jul 23
The US-based clinical-stage company has designed the biomaterial to address the limitations of current embolic solutions for indications…
27 Jul 23
The new study showed that continued algorithm refinement and superior data have improved the accuracy of the technology…
27 Jul 23
QIAGEN is a Netherlands-based holding company providing Sample to Insight solutions that enable customers to gain valuable molecular…
27 Jul 23
The first Flexcera family resin validated for Carbon systems is Desktop Health’s Flexcera Smile Ultra+, an FDA 510(k)…
27 Jul 23
Soin Neuroscience has begun initial testing in humans for safety and tolerability using very low frequency stimulation
26 Jul 23
The FDA approval also includes the company’s core technology platform, the AXINON System, which incorporates diagnostic testing algorithms…
26 Jul 23
The ELEstic device can speed up sample processing, enable more samples to be processed in the same space…
26 Jul 23
The US-based medical technology company has designed Zoom 88 Support to bring the benefits of intracranial access to…